复发性神经内分泌肝转移再次肝切除术与首次肝切除术的比较
该回顾性队列研究纳入1994–2016年因神经内分泌肝转移(NELM)行肝切除术的44例患者,其中28例复发,16例接受再次肝切除术。再次肝切除组总生存显著优于未再手术组(P < .001),而首次与再次肝切除后无进展生存相似(P = .546)。再次肝切除在选定患者中可行。
要点
- 再次肝切除组总生存显著优于未再手术组(P < .001)。
- 首次与再次肝切除后无进展生存相似(P = .546)。
- 未行再次肝切除是复发队列预后不良的独立预测因素(HR 5.0,P = .036)。
核心结论
- 在选定复发性NELM患者中,再次肝切除术是可行的。
研究设计与样本
- 回顾性队列研究,纳入1994–2016年因NELM行肝切除术的44例患者。
- 首次肝切除指征为足够残肝体积且无肝外转移,再次肝切除指征相同。
- 复发诊断基于影像学检查。
主要发现
- 28例复发患者中16例接受再次肝切除,12例未再手术。
- 再次肝切除组(n = 16)总生存显著优于未再手术组(n = 12)(P < .001)。
- 首次肝切除后(n = 44)与再次肝切除后(n = 16)的无进展生存相似(P = .546)。
- 首次与再次肝切除后主要并发症(Clavien-Dindo评分≥3a)频率无显著差异(P = .279)。
关键数值与推荐
- 在复发队列中,未行再次肝切除是预后不良的独立预测因素(HR 5.0,P = .036)。
- 多发结节是预后不良的独立预测因素(HR 26.2,P = .008)。
- CA19-9水平≥40 U/mL是预后不良的独立预测因素(HR 11.2,P = .012)。
临床怎么用
- 对符合首次肝切除指征(足够残肝体积、无肝外转移)的复发性NELM患者,可考虑再次肝切除术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The value of repeat hepatectomy for intrahepatic recurrence after curative resection of neuroendocrine liver metastasis (NELM) remains unclear. The aim of this retrospective cohort study was to determine the significance of repeat hepatectomy for recurrent NELM. METHODS: Patients who underwent hepatectomy for NELM between 1994 and 2016 were identified. The indications for a first hepatectomy were adequate liver remnant volume and no extrahepatic metastasis. The diagnosis of recurrent NELM was based on radiographic examinations. The indications for a repeat hepatectomy were the same as those for the first hepatectomy. Clinicopathologic factors, short-term survival, and long-term survival were investigated using clinical records. RESULTS: Forty-four patients enrolled in this study. Thirty-three patients among them underwent a curative hepatectomy, and 28 of them developed recurrence. Of them, 16 patients underwent a repeat hepatectomy. The overall survival of the repeat hepatectomy cohort (n = 16) was significantly better than that of the no repeat hepatectomy cohort (n = 12) (P < .001). The progression free survival after the first hepatectomy (n = 44) and that after repeat hepatectomy (n = 16) were similar (P = .546). No significant difference was seen between the frequency of major complications (Clavien-Dindo score ≥ 3a) after the first and repeat hepatectomy (P = .279). No repeat hepatectomy (hazard ratio [HR] 5.0, P = .036) was identified as an independent predictive factor of a poor outcome among the recurrent cohort, along with the presence of multiple nodules (HR 26.2, P = .008) and a CA19-9 level ≥40 U/mL (HR 11.2, P = .012). CONCLUSIONS: A repeat hepatectomy is feasible in selected patients with recurrent NELM.
引用
- Kiritani S, Arita J, Matsumura M, et al. Repeat hepatectomy for patients with recurrent neuroendocrine liver metastasis: Comparison with first hepatectomy. Surgery. 2019. PMID: 31635827. doi:10.1016/j.surg.2019.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。